Search Within

Dimitar B Nikolov

Formats
  1. Journal Article (81)
  2. Meeting Abstract (4)
  3. Book Section (1)
  4. Review (1)
Groups
  1. GSK Faculty (87)
  2. Sloan Kettering Institute Faculty (87)
  3. Structural Biology Program Faculty (87)
  4. Sloan Kettering Institute Postdocs (53)
  5. Radiochemistry and Imaging Sciences Service (2)
  6. Radiology, Department of (2)

More Groups

People
  1. Juha Himanen (44)
  2. Kai Xu (21)
  3. Nayanendu Saha (18)
  4. Dorothea Robev (16)
  5. William Barton (15)
  6. Yehuda Goldgur (11)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (4)
  4. 2022 (2)
  5. 2021 (4)
  6. 2020 (1)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (6)
  2. Protein Science (6)
  3. Biochemical and Biophysical Research Communications (3)
  4. Journal of Biological Chemistry (3)
  5. PLoS ONE (3)
  6. Abstracts of Papers of the American Chemical Society (2)

More Publications

Publishers
  1. Wiley Blackwell (11)
  2. Elsevier Inc. (9)
  3. Cell Press (8)
  4. Elsevier Science, Inc. (6)
  5. National Academy of Sciences (6)
  6. Nature Publishing Group (6)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of fine-needle aspiration specimens for molecular analysis of lung adenocarcinoma: A comparative analysis of next-generation sequencing quality metrics
    Meeting Abstract

    Ramineni, M.; Blake, E.; Okutan, S.; Elliott, P.; Nikolov, D.; Jajosky, A.; Cox, A.; Giampoli, E.; Varghese, S.; Oltavi, Z.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors
    Journal Article

    Saha, N.; Chan, E.; Mendoza, R. P.; Romin, Y.; Tipping, M. J.; Nikolov, D. B.
    Life Science Alliance (2025)

    Fulltext@MSK | Save
  • Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells
    Journal Article

    Saha, N.; Lee, S. G.; Brockmann, E. C.; de la Cruz, M. J.; Goldgur, Y.; Mendoza, R. P.; de Stanchina, E.; Love, T. M.; Marvald, J.; Xu, Y.; more...
    Biomedicine and Pharmacotherapy (2024)

    Fulltext@MSK | Save
  • The angiopoietin signaling pathway is involved in inflammatory processes in hospitalized COVID-19 patients
    Journal Article

    Mendoza, R. P.; Momeni, A.; Saha, N.; Arshi, J.; Gabutan, E. C.; Alejandro, N.; Zuretti, A.; Premsrirut, P. K.; Nikolov, D. B.
    Microorganisms (2023)

    Fulltext@MSK | Save
  • Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly
    Journal Article

    Shi, X.; Lingerak, R.; Herting, C. J.; Ge, Y.; Kim, S.; Toth, P.; Wang, W.; Brown, B. P.; Meiler, J.; Sossey-Alaoui, K.; more...
    Science (2023)

    Fulltext@MSK | Save
  • A multipronged unbiased strategy guides the development of an anti-EGFR/EPHA2-bispecific antibody for combination cancer therapy
    Journal Article

    El Zawily, A.; Vizeacoumar, F. S.; Dahiya, R.; Banerjee, S. L.; Bhanumathy, K. K.; Elhasasna, H.; Hanover, G.; Sharpe, J. C.; Sanchez, M. G.; Greidanus, P.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
    Journal Article

    Saha, N.; Baek, D. S.; Mendoza, R. P.; Robev, D.; Xu, Y.; Goldgur, Y.; De La Cruz, M. J.; de Stanchina, E.; Janes, P. W.; Xu, K.; more...
    Biomedicine and Pharmacotherapy (2023)

    Fulltext@MSK | Save
  • Preferential antibody and drug conjugate targeting of the ADAM10 metalloprotease in tumours
    Journal Article

    Yan, H.; Vail, M. E.; Hii, L.; Guo, N.; McMurrick, P. J.; Oliva, K.; Wilkins, S.; Saha, N.; Nikolov, D. B.; Lee, F. T.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • The EphB2 receptor uses homotypic, head-to-tail interactions within its ectodomain as an autoinhibitory control mechanism
    Journal Article

    Xu, Y.; Robev, D.; Saha, N.; Wang, B.; Dalva, M. B.; Xu, K.; Himanen, J. P.; Nikolov, D. B.
    International Journal of Molecular Sciences (2021)

    Fulltext@MSK | Save